chronic obstructive pulmonary disease (COPD)


acriflavine

3,6-diamino-10-methylacridinium chloride compound with 3,6-acridinediamine (1:1)


Zinc Oxide/Aluminum Starch Octenylsuccinate/Glycyrrhetinic Phytosome/Vitamin E/Botanical Extracts-Based Skin Protectant Paste


Lambert-Eaton myasthenic syndrome (LEMS)


recurrent infection of the gastrointestinal tract


Abdominal and Gastrointestinal Infection


chronic lymphocytic leukemia/small lymphocytic lymphoma


betamethasone-phosphate

betamethasone 21-phosphate disodium salt


brequinar

Dihydroorotate Dehydrogenase Inhibitor, Brequinar


brilliant-green

Brilliant Green, pure, high purity biological stain


ciclopirox

6-cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridinone compound with 2-aminoethanol (1:1)


clonixin-lysinate

(2S)-2,6-diaminohexanoic acid compound with 2-(3-chloro-2-methylanilino)nicotinic acid (1:1)


clorotepine

(2Z)-2-butenedioic acid compound with 1-(8-chloro-10,11-dihydrodibenzo[b,f]thiepin-10-yl)-4-methylpiperazine (1:1)


dehydroepiandrosterone-sulfate

sodium (3beta)-17-oxoandrost-5-en-3-yl sulfate dihydrate


diadenosine-tetraphosphate

P1,P4-Di(adenosine-5') tetraphosphate ammonium salt


equine protozoal myeloencephalitis (EPM)


dimemorfan

phosphoric acid compound with (9alpha,13alpha,14alpha)-3,17-dimethylmorphinan (1:1)


dimethindene-(S)-(+)

(2Z)-2-butenedioic acid compound with N,N-dimethyl-2-{3-[(1S)-1-(2-pyridinyl)ethyl]-1H-inden-2-yl}ethanamine (1:1)


head and neck squamous cell carcinoma (HNSCC)


left ventricular systolic dysfunction (LVSD)


percutaneous coronary intervention (PCI)


(2Z)-2-butenedioic acid compound with 10-(3-aminopropyl)-3,4-dimethyl-9(10H)-acridinone (1:1)


abnormal circulating lipid concentration


flavin-adenine-dinucleotide

Flavin adenine dinucleotide disodium salt


hexoprenaline

sulfuric acid compound with 4-{2-[(6-{[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino}hexyl)amino]-1-hydroxyethyl}-1,2-benzenediol (1:1)


Acetyl-(Nle4,Gln5,D-Phe7,D-Trp9)-alpha-MSH (4-10) amide trifluoroacetate salt


HTMT

(2Z)-2-butenedioic acid compound with 6-{[2-(1H-imidazol-4-yl)ethyl]amino}-N-[4-(trifluoromethyl)phenyl]heptanamide (2:1)


hydroxychloroquine

sulfuric acid compound with 2-[{4-[(7-chloro-4-quinolinyl)amino]pentyl}(ethyl)amino]ethanol (1:1)


Leber hereditary optic neuropathy (LHON)


lobeline

sulfuric acid compound with 2-{(2R,6S)-6-[(2S)-2-hydroxy-2-phenylethyl]-1-methyl-2-piperidinyl}-1-phenylethanone (1:2)


(4-formyl-5-hydroxy-6-methyl-3-pyridinyl)methyl dihydrogen phosphate hydrate


meloxicam

sodium 2-methyl-3-{[(5-methyl-1,3-thiazol-2-yl)amino]carbonyl}-2H-1,2-benzothiazin-4-olate 1,1-dioxide hydrate


methylprednisolone-sodium-succinate

Methylprednisolone 21-hemisuccinate (sodium salt)


phenelzine

sulfuric acid compound with 1-(2-phenylethyl)hydrazine (1:1)


Riboflavin 5'-phosphate sodium salt hydrate


Non-Neoplastic Chronic Respiratory System Disorder


sumanirole

(2Z)-2-butenedioic acid compound with (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (1:1)


TBOA-(DL)

(2R,3R)-2-amino-3-(benzyloxy)succinic acid compound with (2S,3S)-2-amino-3-(benzyloxy)succinic acid (1:1)


(2E)-2-butenedioic acid compound with (3E)-4-(5-ethoxy-3-pyridinyl)-N-methyl-3-buten-1-amine (2:1)


telotristat-ethyl

(benzoylamino)acetic acid compound with ethyl (2S)-2-amino-3-{4-[2-amino-6-({(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethyl}oxy)-4-pyrimidinyl]phenyl}propanoate (1:1)


generalized resistance to thyroid hormone